Biotech GSK Expands Oncology Portfolio With $115 Billion Dollar IDRx Acquisition admin Jan 15, 2025 British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a…
Pharmaceutical Carlyle Backed Investor Launches 15 Billion Clinical Trials Fund admin Dec 1, 2024 A significant move in the pharmaceutical investment landscape has emerged as Carlyle-backed Abingworth seeks to…
